EUVIMEDEUVIMED entdecken
Crossref

β-Asaronol, the Neuroactive Component of Acorus tatarinowii : Mitigating Seizures with Minimal Developmental Risk in Dravet Syndrome

Ying Sun, Yajun Bai iD, Bin Li iD, Peinan Fan, Haiyan Lu, Pu Jia iD, Ye Zhao, Yujun Bai, Shixiang Wang, Kechun Liu iD, Meng Jin iD, Tai-Ping Fan und 1 weitere

ACS Chemical Neuroscience · 2025

DOI: 10.1021/acschemneuro.5c00481 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2025. Verfasst von Ying Sun und 12 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, The College of Life Sciences, Northwest University, Xi'…. Hauptthemen laut MEDLINE: Epilepsies, Myoclonic, Anticonvulsants, Seizures, Anisoles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: High-end Foreign Experts Recruitment Plan of China, Taishan Scholar Project of Shandong Province, Key Research and Development Projects of Shaanxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epilepsies, MyoclonicAnticonvulsantsSeizuresAnisolesAllylbenzene DerivativesAcorusAnimalsZebrafishAnimals, Genetically ModifiedMolecular Docking SimulationPentylenetetrazoleDisease Models, Animal

Stichwörter der Autor:innen

Acorus tatarinowiiGABAA receptor modulationantiseizure efficacydevelopmental epileptic encephalopathiesdevelopmental toxicitydravet syndromezebrafish modelsβ-asaronol

Substanzen

AnticonvulsantsAnisolesAllylbenzene DerivativesasaronePentylenetetrazole

Autor:innen und Institutionen

  • Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, The College of Life Sciences, Northwest University, Xi'an 710069, P.R. China.
  • Hong-taoism Research Institute of Analytical Science and Technology Ltd., Xi'an, Shaanxi Province 710068, P.R. China.
  • School of chemical engineering and technology, Xi'an Jiaotong university, Xi'an 710115, P.R. China.
  • Biology Institute, Qilu University of Technology (Shandong Academy of Sciences), 28789 East Jingshi Road, Ji'nan, Shandong Province 250103, P.R. China.
  • Institute of Brain Science and Brain-inspired Research, Shandong First Medical University & Shandong Academy of Medical Sciences, 6699 Qingdao Road, Ji'nan, Shandong Province 250117, P.R. China.
  • School of Life and Health Sciences, Fuyao University of Science and Technology, Fuzhou, Fujian Province 350109, P.R. China.

ORCID-Profile: Yajun Bai, Bin Li, Pu Jia, Kechun Liu, Meng Jin

Förderung

  • High-end Foreign Experts Recruitment Plan of China
  • Taishan Scholar Project of Shandong Province
  • Key Research and Development Projects of Shaanxi Province
  • Shaanxi Province Qinchuangyuan 'Scientists + Engineers' Team Building Initiative
  • Project of Innovative Drug Research Center of Shaanxi Province
  • Critical Core Technology Breakthrough Project in Key Industrial Chains
  • Technology Innovation Guidance Project of Shaanxi Province

Zitieren

APA

Sun, Y., Bai, Y., Li, B., Fan, P., Lu, H., Jia, P., Zhao, Y., Bai, Y., Wang, S., Liu, K., Jin, M., Fan, T. P., & Zheng, X. (2025). β-Asaronol, the Neuroactive Component of Acorus tatarinowii : Mitigating Seizures with Minimal Developmental Risk in Dravet Syndrome. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.5c00481

Vancouver

Sun Y, Bai Y, Li B, Fan P, Lu H, Jia P, et al. β-Asaronol, the Neuroactive Component of Acorus tatarinowii : Mitigating Seizures with Minimal Developmental Risk in Dravet Syndrome. ACS Chemical Neuroscience. 2025. doi:10.1021/acschemneuro.5c00481

BibTeX
@article{Sun2025,
  author = {Sun, Ying and Bai, Yajun and Li, Bin and Fan, Peinan and Lu, Haiyan and Jia, Pu and Zhao, Ye and Bai, Yujun and Wang, Shixiang and Liu, Kechun and Jin, Meng and Fan, Tai-Ping and Zheng, Xiaohui},
  title = {β-Asaronol, the Neuroactive Component of Acorus tatarinowii : Mitigating Seizures with Minimal Developmental Risk in Dravet Syndrome},
  journal = {ACS Chemical Neuroscience},
  year = {2025},
  doi = {10.1021/acschemneuro.5c00481}
}
Kostenlos starten →